SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001137171-05-000350
Filing Date
2005-03-23
Accepted
2005-03-23 13:23:46
Documents
9
Period of Report
2005-01-12

Document Format Files

Seq Description Document Type Size
1 lorus.htm 6-K/A 912803
2 PRESS RELEASE ex9901.htm EX-99 9068
3 PRESS RELEASE ex9902.htm EX-99 14189
4 PRESS RELEASE ex9903.htm EX-99 12386
5 PRESS RELEASE ex9904.htm EX-99 13566
6 PRESS RELEASE ex9905.htm EX-99 10900
7 PRESS RELEASE ex9906.htm EX-99 41234
8 sig1.gif GRAPHIC 18085
9 subscription002.gif GRAPHIC 42962
  Complete submission text file 0001137171-05-000350.txt   1077749
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K/A | Act: 34 | File No.: 001-32001 | Film No.: 05698603
SIC: 2836 Biological Products, (No Diagnostic Substances)